Endocrinology Network Covers GLP-1 Agents for Patients with Type 2 Diabetes
NORWALK, Conn., Feb. 17, 2015 /PRNewswire/ -- UBM Medica US announces that Endocrinology Network, a leading online community for endocrinologists and other clinicians who treat patients with type 2 diabetes (T2DM) offers comprehensive and up-to-date coverage of the glucagon-like peptide-1 (GLP-1) receptor agonists.
The key properties of agents in this expanding class of injectable antidiabetes drugs include powerful A1c-lowering, insulin-independent action (no hypoglycemia), weight loss, and improved satiety. Of the five approved GLP-1 agonists, several are administered once-weekly—a significant benefit to promote patient adherence. With combination products entering the market and new GLP-1 agents in the pipeline, ongoing education will be essential for all clinicians who treat diabetes patients.
Some highlights of GLP-1 agonist coverage include:
- Four Facts to Remember Before Prescribing a GLP-1 Agonist: Clinicians are challenged in this short quiz to recognize facts about mechanism of action, adverse events, contraindications, and concurrent drug use.
- Weight Loss Before Bariatric Surgery in T2DM: GLP-1 Agonist Gets it Done: Pre-surgical weight loss in obese patients with type 2 diabetes reduces perioperative risk. The dual benefits of GLP-1 agonists offer promise to this hard-to-treat population.
- GLP-1 Agonist, Basal Insulin Powerful Against T2DM: A recent meta-analysis found that patients treated with a combination of a GLP-1 agonist and basal insulin had a significantly greater A1c reduction than patients on any other treatment regimen studied.
- Once-Weekly GLP-1 Agonist Added to Oral Agents Lowers A1c: Researchers saw a rapid and durable response to the addition of albiglutide in T2DM patients not reaching glycemic targets on dual oral therapy.
About UBM Medica US
Addressing today's healthcare information needs, UBM Medica US, delivers strategic, integrated communications solutions and comprehensive reach -- online, in print, via custom programs and live events. Improving the effectiveness of healthcare through information and education, UBM Medica US provides unbiased clinical, practical, and business information for physicians, providers and payers resulting in improved quality of care for patients around the world. Through journals, magazines, online communities, live and digital events, and other valuable resources, UBM Medica US also delivers comprehensive communication solutions for the pharmaceutical and related industries. Online communities include CancerNetwork.com, ConsultantLive.com, DiagnosticImaging.com, RheumatologyNetwork.com, OBGYN.net, PhysiciansPractice.com, PsychiatricTimes.com and SearchMedica.com. UBM Medica US is part of UBM Connect which, through a range of aligned interactive environments, both physical and digital – increases business effectiveness for both customers and audiences through meaningful experiences, knowledge and connections. Headquartered in New York, UBM Connect brings together UBM's healthcare business, UBM Medica US; UBM Canon's advanced design and manufacturing event, online and print brands; UBM Connect New York's catering, cruise shipping, customer management, and fine, specialty and custom chemical communities; and UBM Mexico's concrete show. For more information, visit www.UBMMedicaUS.com.
About UBM plc
UBM plc is a global events-led marketing services and communications company. We help businesses do business, bringing the world's buyers and sellers together at events and online, as well as producing and distributing news and specialist content. Our 5,500 staff in more than 30 countries are organized into expert teams which serve commercial and professional communities, helping them to do business and their markets to work effectively and efficiently.
For more information, go to www.ubm.com; follow us on Twitter at @UBM_plc to get the latest UBM corporate news.
Media contact:
Jason J. Golden
Content Marketing Manager
203-523-7040
Logo - http://photos.prnewswire.com/prnh/20150217/175999LOGO
SOURCE UBM Medica US
Related Links
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
Newsrooms &
Influencers
Digital Media
Outlets
Journalists
Opted In
Share this article